Tuesday

Plenary Session

Research presented in the Plenary Session compared quality of life outcomes between radiation therapy modalities for locally advanced breast and oropharyngeal cancers and looked at advances in radiation therapy for treating prostate cancer, bladder cancer and brain metastases resulting from non-small cell lung cancer.

Keynote I - Bobby Makkamala, MD

Bobby Mukkamala, MD, a board-certified otolaryngologist, head and neck surgeon, and the president of the American Medical Association, shares how his cancer experience informs leadership priorities during his Keynote Address.

ML Holds Promise for Predicting Acute Care Risk

Although most studies remain retrospective, SHIELD-RT represents one of the first prospective, interventional ML trials, providing valuable insights into clinical workflow integration and resource allocation.
By Jackie Wu, PhD, Duke University Medical Center

Is Simulation-free RT in Our Future?

This study demonstrates a direct-to-unit adaptive SBRT workflow that eliminates CT simulation by using diagnostic PET-CT for treatment planning and daily CBCT for adaptation.
By Jackie Wu, PhD, Duke University Medical Centery

Survivor Circle Grant

Sunday afternoon, ASTRO awarded this year’s recipients, Carter’s Foundation and Latinas Contra Cancer, with Survivor Circle Grants of $12,500 each for the services they provide.